insurance glp 1 companies scrambling to support need for GLP-1 drugs - The C.O.R.E. Group GLP-1 medications are transforming medical

2021;16(1) doi: 10.1371/journal.pone.0244847

GLP-1 based therapies:differential effects on fasting and postprandial glucose

Critics argue aggressive direct-to-consumer advertising may encourage inappropriate prescribing and higher costs

Trulicity is not indicated for type 1 diabetes

Over time, AS plaques form fibrous caps and accumulate calcium salts

Renal Impairment: In patients treated with GLP-1 receptor agonists, including Saxenda , there have been reports of acute renal failure and worsening of chronic renal failure, usually in association with nausea, vomiting, diarrhea, or dehydration, which may sometimes require hemodialysis